Science Explorer Back to mapMap
Discussion
Researcher · Ichimaru Pharcos (Japan) · Japan

Kotaro Sakamoto

Kotaro Sakamoto publishes mostly in Molecular Biology, Oncology and Cellular and Molecular Neuroscience, on topics such as Neuropeptides and Animal Physiology, Monoclonal and Polyclonal Antibodies Research and Glycosylation and Glycoproteins Research.

ORCID 0000-0003-1295-1623 OpenAlex
World rank
#4,543,685
of 7,710,434 ranked researchers
Rank in Japan
#132,943
of 383,136
Works
88
Citations
1.6k
Citations per work
18.2
h-index
23
i10-index 45Top 26% in Molecular Biology
Kotaro Sakamoto

What does Kotaro Sakamoto research?

Kotaro Sakamoto's work is mostly in Biochemistry, Genetics and Molecular Biology (41%), Medicine (12%), Neuroscience (6%).

Life Sciences: 44 works · 50.0% of their workBiochemistry, Genetics and Molecular Biology: 36 works · 40.7% of their workMolecular Biology: 34 works · 38.4% of their workCancer Research: 2 works · 2.3% of their workNeuroscience: 5 works · 6.2% of their workCellular and Molecular Neuroscience: 5 works · 6.2% of their workImmunology and Microbiology: 3 works · 3.1% of their workImmunology: 3 works · 3.1% of their workEverything else: 33 works · 37.6% of their workHealth Sciences: 11 works · 12.4% of their workMedicine: 11 works · 12.4% of their workOncology: 6 works · 6.6% of their workRadiology, Nuclear Medicine and Imaging: 5 works · 5.8% of their workTHEIR WORKKotaro Sakamoto88works
Life Sciences50%Health Sciences12%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3640.7%
    2. Neuroscience56.2%
    3. Immunology and Microbiology33.1%
  2. Everything else3337.6%
    1. Medicine1112.4%
  1. 1Molecular Biology38% of their works
  2. 2Oncology7% of their works
  3. 3Cellular and Molecular Neuroscience6% of their works
  4. 4Radiology, Nuclear Medicine and Imaging6% of their works
  5. 5Immunology3% of their works
  6. 6Cancer Research2% of their works

Research topics

Which keywords describe Kotaro Sakamoto's research?

The keywords of their largest research topics: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Drug Discovery, Neuropeptides, Receptors, Antibody Engineering and Fc Receptors.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Glycosylation272 topics
  2. Monoclonal Antibodies202 topics
  3. Therapeutic Antibodies202 topics
  4. Drug Discovery192 topics
  5. Neuropeptides161 topic
  6. Receptors161 topic
  7. Antibody Engineering151 topic
  8. Fc Receptors151 topic
  9. Cancer121 topic
  10. Glycans121 topic
  11. Crystal Structure111 topic
  12. G-Protein-Coupled Receptors111 topic
  13. Foldamers81 topic
  14. Peptide Synthesis81 topic
  15. Protein Kinases61 topic
  16. Ras Signaling61 topic
  17. Biopharmaceuticals51 topic
  18. Protein Aggregation51 topic
  19. RNA Interference51 topic
  20. siRNA Delivery51 topic

Where does Kotaro Sakamoto work?

Kotaro Sakamoto's main affiliation in the publication record is Ichimaru Pharcos (Japan), Japan.

How many publications and citations does Kotaro Sakamoto have?

OpenAlex counts 88 works and 1,605 citations for Kotaro Sakamoto, an h-index of 23, ranking #4,543,685 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Other researchers named Kotaro Sakamoto

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Kotaro Sakamoto. Posts are plain text and can be reported.